LEXINGTON, Mass.--(BUSINESS WIRE)--BioScale, Inc. a life science company that develops ultrasensitive protein analysis technology, today announced the appointment of Martin Latterich, PhD as Chief Scientific Officer (CSO). Dr. Latterich brings nearly 20 years of academic, commercial and technology development experience to BioScale and features an accomplished research career focused on the proteomics-based discovery of novel biomarkers in oncology, respiratory disease and neurodegenerative disorders.
